Khosla Ventures Acquisition Co.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KVSA research report →
Price Chart
About the company
Khosla Ventures Acquisition Co. currently lacks substantial business activities. Its core mission is to execute a strategic union with one or multiple companies, potentially through a merger, an equity swap, an asset acquisition, a stock transaction, a corporate reorganization, or a comparable arrangement.
- CEO
- Samir Kaul
- IPO
- 2021
- HQ
- Menlo Park, CA, US
Get TickerSpark's AI analysis on KVSA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $74.29M
- P/E
- 50.95
- PEG
- -0.03
- P/S
- 0.00
- P/B
- 1.03
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.01%
- ROIC
- -0.27%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-2,250,380
- Net Income
- $1.87M+113.5%
- EPS
- $0.05+112.1%
- OCF Growth
- +272.9%
- FCF Growth
- +272.9%
- 52W High
- $11.22
- 52W Low
- $9.94
- 50D MA
- $10.60
- 200D MA
- $10.43
- Beta
- 0.07
- Avg Volume
- 8.04K
No earnings-call transcripts are available for KVSA yet.
of shares held by institutions
10 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Davidson Kempner Partners | 550.00K | ▲ 550.00K |
| Castle Creek Arbitrage, LLC | 157.07K | ▼ 28.31K |
| Evolution Capital Management LLC | 45.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 8, 21 | KHOSLA VINOD | other | 990,000 |
| Mar 8, 21 | Kaul Samir | other | 990,000 |
| Mar 3, 21 | Shklovsky Dmitri | other | 40,000 |
| Mar 3, 21 | Coye Molly Joel | other | 40,000 |
| Mar 3, 21 | West Derek Anthony | other | 40,000 |
| Mar 3, 21 | Singh Jagdeep | other | 40,000 |
| Mar 3, 21 | Buckland Peter | other | 0 |
| Mar 3, 21 | Shah Rajiv | other | 40,000 |
| Mar 3, 21 | Kaul Samir | other | 4,760,000 |
| Mar 3, 21 | Kaul Samir | other | 5,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our KVSA coverage
Recent articles, reports, and earnings notes.
No research on KVSA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KVSA report →Khosla Ventures Acquisition Co. Announces Redemption of Public Shares and Subsequent Dissolution
prnewswire.com · Dec 4
Here's why sodium-ion batteries are shaping up to be a big technology breakthrough
cnbc.com · May 10
Khosla Ventures/Valo Health De-SPAC: Heed The Sponsor's Advice And Stay Away
seekingalpha.com · Jun 10
Valo Health To Combine With Vinod Khosla-Backed SPAC In $2.8B Deal
benzinga.com · Jun 9
The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition
invezz.com · Jun 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.